Molecular Partners AG
MOLN3.650USD
+0.120+3.40%
Market hours （ET）Quotes delayed by 15 min
134.55MMarket Cap
LossP/E TTM
More Details of Molecular Partners AG Company
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Company Info
Ticker SymbolMOLN
Company nameMolecular Partners AG
IPO dateOct 22, 2014
CEODr. Patrick Amstutz, Ph.D.
Number of employees159
Security typeOrdinary Share
Fiscal year-endOct 22
AddressWagistrasse 14
CitySCHLIEREN
Stock exchangeSIX Swiss Exchange
CountrySwitzerland
Postal code8952
Phone41447557700
Websitehttps://www.molecularpartners.com/
Ticker SymbolMOLN
IPO dateOct 22, 2014
CEODr. Patrick Amstutz, Ph.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Renate Gloggner
Ms. Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Executive Vice President - People and Community, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Alexander Zuercher
Mr. Alexander Zuercher
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Revenue Breakdown
Currency: CHFUpdated: Sun, Jul 6
Currency: CHFUpdated: Sun, Jul 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionCHF
Name
Revenue
Proportion
Switzerland
4.97M
0.00%
United States
0.00
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Suvretta Capital Management, LLC
6.03%
BVF Partners L.P.
3.67%
UBS Financial Services, Inc.
0.02%
Other
90.28%
Shareholders
Shareholders
Proportion
Suvretta Capital Management, LLC
6.03%
BVF Partners L.P.
3.67%
UBS Financial Services, Inc.
0.02%
Other
90.28%
Shareholder Types
Shareholders
Proportion
Hedge Fund
9.70%
Investment Advisor
0.02%
Other
90.28%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
16
3.58M
9.72%
-44.38K
2025Q1
16
3.58M
9.72%
-44.38K
2024Q4
16
3.58M
10.80%
+1.75M
2024Q3
19
850.31K
2.56%
-138.97K
2024Q2
20
861.27K
2.60%
-213.87K
2024Q1
22
946.77K
2.88%
-611.83K
2023Q4
26
957.56K
2.63%
-624.65K
2023Q3
28
961.52K
2.93%
-686.56K
2023Q2
36
934.21K
2.85%
-1.24M
2023Q1
36
935.03K
2.59%
-1.23M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Suvretta Capital Management, LLC
2.22M
6.03%
--
--
Mar 31, 2025
BVF Partners L.P.
1.35M
3.67%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
6.35K
0.02%
-521.00
-7.58%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.07K
0%
--
--
May 31, 2025
Morgan Stanley & Co. LLC
367.00
0%
--
--
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
269.00
0%
--
--
Mar 31, 2025
BofA Global Research (US)
157.00
0%
+157.00
--
Mar 31, 2025
Qube Research & Technologies Ltd
--
0%
-16.00
-100.00%
Sep 30, 2024
Old Mission Capital LLC
--
0%
-10.37K
-100.00%
Sep 30, 2024
Susquehanna International Group, LLP
--
0%
-12.62K
-100.00%
Mar 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
